These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17982029)

  • 1. The activating immunoreceptor NKG2D and its ligands are involved in allograft transplant rejection.
    Kim J; Chang CK; Hayden T; Liu FC; Benjamin J; Hamerman JA; Lanier LL; Kang SM
    J Immunol; 2007 Nov; 179(10):6416-20. PubMed ID: 17982029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of natural killer cell subsets in cardiac allograft rejection.
    McNerney ME; Lee KM; Zhou P; Molinero L; Mashayekhi M; Guzior D; Sattar H; Kuppireddi S; Wang CR; Kumar V; Alegre ML
    Am J Transplant; 2006 Mar; 6(3):505-13. PubMed ID: 16468959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
    Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts.
    van der Touw W; Burrell B; Lal G; Bromberg JS
    Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of NKG2D and its ligand in mouse heart allografts may have a role in acute rejection.
    Feng L; Ke N; Ye Z; Guo Y; Li S; Li Q; Li Y
    Transplant Proc; 2009 Dec; 41(10):4332-9. PubMed ID: 20005394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.
    Wiemann K; Mittrücker HW; Feger U; Welte SA; Yokoyama WM; Spies T; Rammensee HG; Steinle A
    J Immunol; 2005 Jul; 175(2):720-9. PubMed ID: 16002667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK cells rapidly reject allogeneic bone marrow in the spleen through a perforin- and Ly49D-dependent, but NKG2D-independent mechanism.
    Hamby K; Trexler A; Pearson TC; Larsen CP; Rigby MR; Kean LS
    Am J Transplant; 2007 Aug; 7(8):1884-96. PubMed ID: 17617852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the rat NKG2D ligands, RAE1L and RRLT, and their role in allograft rejection.
    Zhuo M; Fujiki M; Wang M; Piard-Ruster K; Wai LE; Wei L; Martinez OM; Krams SM
    Eur J Immunol; 2010 Jun; 40(6):1748-57. PubMed ID: 20306467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway.
    Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K
    Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation.
    Lin CM; Gill RG; Mehrad B
    Am J Transplant; 2021 Nov; 21(11):3550-3560. PubMed ID: 34014614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the NKG2D immunoreceptor in immune cell activation and natural killing.
    Jamieson AM; Diefenbach A; McMahon CW; Xiong N; Carlyle JR; Raulet DH
    Immunity; 2002 Jul; 17(1):19-29. PubMed ID: 12150888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo.
    Yamada A; Salama AD; Sho M; Najafian N; Ito T; Forman JP; Kewalramani R; Sandner S; Harada H; Clarkson MR; Mandelbrot DA; Sharpe AH; Oshima H; Yagita H; Chalasani G; Lakkis FG; Auchincloss H; Sayegh MH
    J Immunol; 2005 Feb; 174(3):1357-64. PubMed ID: 15661893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role of NKG2D and its ligands in organ transplantation: new target for immunointervention.
    Suárez-Alvarez B; López-Vázquez A; Baltar JM; Ortega F; López-Larrea C
    Am J Transplant; 2009 Feb; 9(2):251-7. PubMed ID: 19178412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus serotype 5 E1A sensitizes tumor cells to NKG2D-dependent NK cell lysis and tumor rejection.
    Routes JM; Ryan S; Morris K; Takaki R; Cerwenka A; Lanier LL
    J Exp Med; 2005 Dec; 202(11):1477-82. PubMed ID: 16314433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor.
    Zhou H; Luo Y; Lo JF; Kaplan CD; Mizutani M; Mizutani N; Lee JD; Primus FJ; Becker JC; Xiang R; Reisfeld RA
    Proc Natl Acad Sci U S A; 2005 Aug; 102(31):10846-51. PubMed ID: 16040807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
    Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
    J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-21 enhances tumor rejection through a NKG2D-dependent mechanism.
    Takaki R; Hayakawa Y; Nelson A; Sivakumar PV; Hughes S; Smyth MJ; Lanier LL
    J Immunol; 2005 Aug; 175(4):2167-73. PubMed ID: 16081783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway.
    Westwood JA; Kelly JM; Tanner JE; Kershaw MH; Smyth MJ; Hayakawa Y
    J Immunol; 2004 Jan; 172(2):757-61. PubMed ID: 14707044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the activating NK cell receptor NKG2D accelerates rejection of cardiac allografts.
    Fabritius C; Ritschl PV; Resch T; Roth M; Ebner S; Günther J; Mellitzer V; Nguyen AV; Pratschke J; Sauter M; Klingel K; Kotsch K
    Am J Transplant; 2017 Dec; 17(12):3199-3209. PubMed ID: 28805342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.